PE20080098A1 - Metodo para preparar compuestos intermedios de quinolina 4-halogenada - Google Patents
Metodo para preparar compuestos intermedios de quinolina 4-halogenadaInfo
- Publication number
- PE20080098A1 PE20080098A1 PE2007000621A PE2007000621A PE20080098A1 PE 20080098 A1 PE20080098 A1 PE 20080098A1 PE 2007000621 A PE2007000621 A PE 2007000621A PE 2007000621 A PE2007000621 A PE 2007000621A PE 20080098 A1 PE20080098 A1 PE 20080098A1
- Authority
- PE
- Peru
- Prior art keywords
- compounds
- halogenated
- alkinyl
- alkenyl
- quinoline
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 abstract 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 abstract 2
- 102000027426 receptor tyrosine kinases Human genes 0.000 abstract 2
- 108091008598 receptor tyrosine kinases Proteins 0.000 abstract 2
- NRKYWOKHZRQRJR-UHFFFAOYSA-N 2,2,2-trifluoroacetamide Chemical compound NC(=O)C(F)(F)F NRKYWOKHZRQRJR-UHFFFAOYSA-N 0.000 abstract 1
- 101100313649 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) POT1 gene Proteins 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
- 101100161758 Yarrowia lipolytica (strain CLIB 122 / E 150) POX3 gene Proteins 0.000 abstract 1
- 239000003637 basic solution Substances 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001296 polysiloxane Polymers 0.000 abstract 1
- 229910000027 potassium carbonate Inorganic materials 0.000 abstract 1
- 235000015320 potassium carbonate Nutrition 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 239000011541 reaction mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
Abstract
SE REFIERE A UN PROCEDIMIENTO DE PREPARACION DE COMPUESTOS DE QUINOLINA 4-HALOGENADA DE FORMULA (I) QUE COMPRENDE: A) HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON EL REACTIVO POX3 EN PRESENCIA DE UN GEL DE SILICE A UNA TEMPERATURA DE 80 ºC A 85 ºC, DONDE X ES HALO; PG ES UN GRUPO PROTECTOR TAL COMO CH3OC(O), TRIFLUOROACETAMIDA, BENZAMIDA, ENTRE OTROS; A ES O, S O NR, DONDE R ES H, ALQUILO(C1-C6), ALQUENILO(C2-C6) O ALQUINILO(C2-C6); G, R1 Y R4 SON CADA UNO H, HALOGENO, ALQUILO(C1-C6), ALQUENILO(C2-C6), ALQUINILO(C2-C6), ENTRE OTROS; B) FILTRAR LA MEZCLA DE REACCION A TRAVES DE CELITE; C) TEMPLAR EL LIQUIDO FILTRADO CON UNA SOLUCION BASICA TAL COMO K2CO3; Y D) FILTRAR LA MEZCLA TEMPLADA PARA AISLAR EL COMPUESTO DE FORMULA (I). DICHOS COMPUESTOS SON INTERMEDIARIOS EN LA PRODUCCION DE COMPUESTOS INHIBIDORES DEL RECEPTOR DE TIROSINA QUINASA (RTK)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80275906P | 2006-05-23 | 2006-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20080098A1 true PE20080098A1 (es) | 2008-03-31 |
Family
ID=38566902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007000621A PE20080098A1 (es) | 2006-05-23 | 2007-05-21 | Metodo para preparar compuestos intermedios de quinolina 4-halogenada |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20070281932A1 (es) |
| EP (1) | EP2027094A2 (es) |
| JP (1) | JP2009538306A (es) |
| KR (1) | KR20090010084A (es) |
| CN (1) | CN101448790A (es) |
| AR (1) | AR061098A1 (es) |
| AU (1) | AU2007268058A1 (es) |
| CA (1) | CA2651448A1 (es) |
| CR (1) | CR10453A (es) |
| EC (1) | ECSP088901A (es) |
| GT (1) | GT200800255A (es) |
| IL (1) | IL195111A0 (es) |
| MX (1) | MX2008014899A (es) |
| NO (1) | NO20084651L (es) |
| PE (1) | PE20080098A1 (es) |
| RU (1) | RU2008143595A (es) |
| TW (1) | TW200808728A (es) |
| WO (1) | WO2007139797A2 (es) |
| ZA (1) | ZA200809964B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101313702B1 (ko) | 2005-02-03 | 2013-10-04 | 와이어쓰 | 제피티니브 및/또는 에를로티니브 내성암 치료용 약제학적 조성물 |
| EP1942937A1 (en) | 2005-11-04 | 2008-07-16 | Wyeth | Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272 |
| US8022216B2 (en) | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| BRPI0914790A2 (pt) | 2008-06-17 | 2015-10-20 | Wyeth Llc | uso de um composto de vinorelbina e um composto de hki-272, composição farmacêutica e produto e kit para o tratamento de neoplasma |
| US8669273B2 (en) | 2008-08-04 | 2014-03-11 | Wyeth Llc | Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine |
| DK3000467T3 (da) | 2009-04-06 | 2023-03-27 | Wyeth Llc | Behandling med neratinib mod brystkræft |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6002008A (en) * | 1997-04-03 | 1999-12-14 | American Cyanamid Company | Substituted 3-cyano quinolines |
| US6297258B1 (en) * | 1998-09-29 | 2001-10-02 | American Cyanamid Company | Substituted 3-cyanoquinolines |
| US6288082B1 (en) * | 1998-09-29 | 2001-09-11 | American Cyanamid Company | Substituted 3-cyanoquinolines |
| US6533208B1 (en) * | 1999-08-12 | 2003-03-18 | Axis U.S.A., Inc. | Winding cores with stratification motion |
| TWI275390B (en) * | 2002-04-30 | 2007-03-11 | Wyeth Corp | Process for the preparation of 7-substituted-3- quinolinecarbonitriles |
| US7399865B2 (en) * | 2003-09-15 | 2008-07-15 | Wyeth | Protein tyrosine kinase enzyme inhibitors |
| GT200500008A (es) * | 2004-01-16 | 2005-08-16 | Intermediarios de quinolina como inhibidores de receptores de tirosina quinasas y la sintesis de los mismos |
-
2007
- 2007-04-25 TW TW096114597A patent/TW200808728A/zh unknown
- 2007-05-21 PE PE2007000621A patent/PE20080098A1/es not_active Application Discontinuation
- 2007-05-22 AR ARP070102210A patent/AR061098A1/es unknown
- 2007-05-23 CN CNA2007800187406A patent/CN101448790A/zh active Pending
- 2007-05-23 US US11/802,430 patent/US20070281932A1/en not_active Abandoned
- 2007-05-23 EP EP07795194A patent/EP2027094A2/en not_active Withdrawn
- 2007-05-23 JP JP2009512114A patent/JP2009538306A/ja not_active Withdrawn
- 2007-05-23 AU AU2007268058A patent/AU2007268058A1/en not_active Abandoned
- 2007-05-23 RU RU2008143595/04A patent/RU2008143595A/ru not_active Application Discontinuation
- 2007-05-23 MX MX2008014899A patent/MX2008014899A/es unknown
- 2007-05-23 CA CA002651448A patent/CA2651448A1/en not_active Abandoned
- 2007-05-23 WO PCT/US2007/012211 patent/WO2007139797A2/en not_active Ceased
- 2007-05-23 KR KR1020087029059A patent/KR20090010084A/ko not_active Withdrawn
-
2008
- 2008-11-04 IL IL195111A patent/IL195111A0/en unknown
- 2008-11-05 NO NO20084651A patent/NO20084651L/no not_active Application Discontinuation
- 2008-11-21 CR CR10453A patent/CR10453A/es not_active Application Discontinuation
- 2008-11-21 EC EC2008008901A patent/ECSP088901A/es unknown
- 2008-11-21 GT GT200800255A patent/GT200800255A/es unknown
- 2008-11-24 ZA ZA200809964A patent/ZA200809964B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2008143595A (ru) | 2010-06-27 |
| KR20090010084A (ko) | 2009-01-28 |
| WO2007139797A2 (en) | 2007-12-06 |
| WO2007139797A3 (en) | 2008-03-13 |
| AU2007268058A1 (en) | 2007-12-06 |
| ZA200809964B (en) | 2009-09-30 |
| US20070281932A1 (en) | 2007-12-06 |
| NO20084651L (no) | 2008-12-16 |
| IL195111A0 (en) | 2009-09-22 |
| CN101448790A (zh) | 2009-06-03 |
| JP2009538306A (ja) | 2009-11-05 |
| CA2651448A1 (en) | 2007-12-06 |
| EP2027094A2 (en) | 2009-02-25 |
| ECSP088901A (es) | 2008-12-30 |
| MX2008014899A (es) | 2008-12-01 |
| GT200800255A (es) | 2009-03-18 |
| TW200808728A (en) | 2008-02-16 |
| AR061098A1 (es) | 2008-08-06 |
| CR10453A (es) | 2009-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20080098A1 (es) | Metodo para preparar compuestos intermedios de quinolina 4-halogenada | |
| AR073003A1 (es) | Proceso para preparar 5-azacitosina nucleosidos y sus derivados | |
| PE20050896A1 (es) | Intermediarios de quinolina como inhibidores de tirosina quinasas de receptores y la sintesis de los mismos | |
| BRPI0713190A2 (pt) | método para a preparação de um composto | |
| PE20181492A1 (es) | Compuestos sustituidos de 4-fenilpiridina como agonistas de tgr5 no sistemicos | |
| PE20161405A1 (es) | Analogos de cortistatina y sintesis y usos de los mismos | |
| AR072557A1 (es) | Proceso para preparar composiciones de medicamentos que contienen dabigatran | |
| AR061369A1 (es) | Derivados de pirimidina y composiciones farmaceuticas que los comprenden | |
| PE20200387A1 (es) | Proceso novedoso para la elaboracion de compuestos para su uso en el tratamiento del cancer | |
| ECSP099338A (es) | Derivados de quiniclidina de ácido (hetero) arilcicloheptano carboxíclico como antagonistas del receptor muscarínico | |
| PE20070706A1 (es) | Nuevos derivados imidazopiridina como antagonistas de adenosina a2b | |
| AR069607A1 (es) | Inhibidores de la estearoil-coa desaturasa | |
| PE20160240A1 (es) | Nuevos derivados de indolizina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| BRPI0814529B8 (pt) | derivados de 2,3-dihidrobenzo[1,4]dioxin-2-ilmetil como antagonistas de alfa2c para uso no tratamento de doenças do sistema nervoso periférico e central | |
| PE20121047A1 (es) | Derivados de tiazolilpiperidina como fungicidas | |
| BR112016013874A2 (pt) | Fenil-triazolo-piridina, seus usos, seus processo de produção e seus intermediários, e composição farmacêutica | |
| BRPI0900983A2 (pt) | compostos de diometina, processo para sua preparação e composições farmacêuticas contendo os mesmos | |
| BR112016018851A8 (pt) | processo para fornecer um composto de fórmula (iv) | |
| PE20070007A1 (es) | Metodos para sintetizar derivados de 6-alquilaminoquinolina | |
| PE20131128A1 (es) | Metodo de produccion de un compuestos intermediario para sintetizar un medicamento | |
| MX350024B (es) | Formas polimorfas del ácido 4-{[4-({[4-(2,2,2-trifluoroetoxi)-1,2- benzisoxazol-3-il]oxi}metil)piperidin-1-il]metil}-tetrahidro-2h-p iran-4-carboxílico. | |
| AR055667A1 (es) | Compuestos de (piran-piperidinil)becimidazol, composicion farmaceutica que lo comprende, su uso para preparar un medicamento para el tratamiento de trastornos mediados por el agonismo del receptor m1, procesos para prepararlo y compuestos de utilidad como intermediarios de la sintesis de los mismos. | |
| CO6351781A2 (es) | Derivados de isoquinolinona como antagonistas de nk3 | |
| UY33722A (es) | Oxazolidinonas como moduladores de mglur5 | |
| AR116733A2 (es) | Procesos mejorados para la preparación de compuestos de 1-aril-5-alquil pirazol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FX | Voluntary withdrawal |